Identification of therapeutic targets for Alzheimer's disease via differentially expressed gene and weighted gene co-expression network analyses

Jia,Yujie; Nie,Kun; Li,Jing; Liang,Xinyue; Zhang,Xuezhu

doi:10.3892/mmr.2016.5828

Identification of therapeutic targets for Alzheimer's disease via differentially expressed gene and weighted gene co-expression network analyses

Authors:
- Yujie Jia
- Kun Nie
- Jing Li
- Xinyue Liang
- Xuezhu Zhang
View Affiliations

Affiliations: Institute of Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, P.R. China, Personnel Department, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, P.R. China
Published online on: October 12, 2016 https://doi.org/10.3892/mmr.2016.5828
Pages: 4844-4848

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In order to investigate the pathogenic targets and associated biological process of Alzheimer's disease in the present study, mRNA expression profiles (GSE28146) and microRNA (miRNA) expression profiles (GSE16759) were downloaded from the Gene Expression Omnibus database. In GSE28146, eight control samples, and Alzheimer's disease samples comprising seven incipient, eight moderate, seven severe Alzheimer's disease samples, were included. The Affy package in R was used for background correction and normalization of the raw microarray data. The differentially expressed genes (DEGs) and differentially expressed miRNAs were identified using the Limma package. In addition, mRNAs were clustered using weighted gene correlation network analysis, and modules found to be significantly associated with the stages of Alzheimer's disease were screened out. The Database for Annotation, Visualization, and Integrated Discovery was used to perform Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses. The target genes of the differentially expressed miRNAs were identified using the miRWalk database. Compared with the control samples, 175,59 genes and 90 DEGs were identified in the incipient, moderate and severe Alzheimer's disease samples, respectively. A module, which contained 1,592 genes was found to be closely associated with the stage of Alzheimer's disease and biological processes. In addition, pathways associated with Alzheimer's disease and other neurological diseases were found to be enriched in those genes. A total of 139 overlapped genes were identified between those genes and the DEGs in the three groups. From the miRNA expression profiles, 189 miRNAs were found differentially expressed in the samples from patients with Alzheimer's disease and 1,647 target genes were obtained. In addition, five overlapped genes were identified between those 1,647 target genes and the 139 genes, and these genes may be important pathogenic targets for Alzheimer's disease. Through bioinformatics analysis, potential therapeutic targets and associated biological processes were identified, which may assist in understanding and treatment of Alzheimer's disease.

View Figures

View References

1	Sosa AL, Albanese E, Stephan BC, Dewey M, Acosta D, Ferri CP, Guerra M, Huang Y, Jacob KS, Jiménez-Velázquez IZ, et al: Prevalence, distribution, and impact of mild cognitive impairment in Latin America, China and India: A 10/66 population-based study. PLoS Med. 9:e10011702012. View Article : Google Scholar : PubMed/NCBI
2	Ashby-Mitchell K, Jagger C, Fouweather T and Anstey KJ: Life expectancy with and without cognitive impairment in seven Latin American and Caribbean countries. PloS One. 10:e01218672015. View Article : Google Scholar : PubMed/NCBI
3	Price DL, Tanzi RE, Borchelt DR and Sisodia SS: Alzheimer's disease: Genetic studies and transgenic models. Annu Rev Genet. 32:461–493. 1998. View Article : Google Scholar : PubMed/NCBI
4	Barnes DE and Yaffe K: The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 10:819–828. 2011. View Article : Google Scholar : PubMed/NCBI
5	Huang Y and Mucke L: Alzheimer mechanisms and therapeutic strategies. Cell. 148:1204–1222. 2012. View Article : Google Scholar : PubMed/NCBI
6	Gregory RI and Shiekhattar R: MicroRNA biogenesis and cancer. Cancer Res. 65:3509–3512. 2005. View Article : Google Scholar : PubMed/NCBI
7	Tan JR, Tan KS, Koo YX, Yong FL, Wang CW, Armugam A and Jeyaseelan K: Blood microRNAs in low or no risk ischemic stroke patients. Int J Mol Sci. 14:2072–2084. 2013. View Article : Google Scholar : PubMed/NCBI
8	Balasubramanyam M, Aravind S, Gokulakrishnan K, Prabu P, Sathishkumar C, Ranjani H and Mohan V: Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes. Mol Cell Biochem. 351:197–205. 2011. View Article : Google Scholar : PubMed/NCBI
9	Minones-Moyano E, Porta S, Escaramis G, Rabionet R, Iraola S, Kagerbauer B, Espinosa-Parrilla Y, Ferrer I, Estivill X and Martí E: MicroRNA profiling of parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum Mol Genet. 20:3067–3078. 2011. View Article : Google Scholar : PubMed/NCBI
10	Argyropoulos C, Wang K, McClarty S, Huang D, Bernardo J, Ellis D, Orchard T, Galas D and Johnson J: Urinary microRNA profiling in the nephropathy of type 1 diabetes. PLoS One. 8:e546622013. View Article : Google Scholar : PubMed/NCBI
11	Salas-Pérez F, Codner E, Valencia E, Pizarro C, Carrasco E and Pérez-Bravo F: MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells (PBMCs) from patients with type 1 diabetes. Immunobiology. 218:733–737. 2013. View Article : Google Scholar : PubMed/NCBI
12	Langfelder P and Horvath S: WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
13	Blalock EM, Buechel HM, Popovic J, Geddes JW and Landfield PW: Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease. J Chem Neuroanat. 42:118–126. 2011. View Article : Google Scholar : PubMed/NCBI
14	Nunez-Iglesias J, Liu CC, Morgan TE, Finch CE and Zhou XJ: Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation. PLoS One. 5:e88982010. View Article : Google Scholar : PubMed/NCBI
15	Gautier L, Cope L, Bolstad BM and Irizarry RA: Affy-analysis of affymetrix genechip data at the probe level. Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
16	Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W and Smyth GK: Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43:e472015. View Article : Google Scholar : PubMed/NCBI
17	Dweep H, Sticht C, Pandey P and Gretz N: miRWalk-database: Prediction of possible miRNA binding sites by ‘walking’ the genes of three genomes. J Biomed Inform. 44:839–847. 2011. View Article : Google Scholar : PubMed/NCBI
18	Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
19	Mason JM, Morrison DJ, Basson MA and Licht JD: Sprouty proteins: Multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. Trends Cell Biol. 16:45–54. 2006. View Article : Google Scholar : PubMed/NCBI
20	Kim HJ and Bar-Sagi D: Modulation of signalling by Sprouty: A developing story. Nat Rev Mol Cell Biol. 5:441–450. 2004. View Article : Google Scholar : PubMed/NCBI
21	Mailleux AA, Tefft D, Ndiaye D, Itoh N, Thiery JP, Warburton D and Bellusci S: Evidence that SPROUTY2 functions as an inhibitor of mouse embryonic lung growth and morphogenesis. Mech Dev. 102:81–94. 2001. View Article : Google Scholar : PubMed/NCBI
22	Gross I, Morrison DJ, Hyink DP, Georgas K, English MA, Mericskay M, Hosono S, Sassoon D, Wilson PD, Little M and Licht JD: The receptor tyrosine kinase regulator sprouty1 is a target of the tumor suppressor WT1 and important for kidney development. J Biol Chem. 278:41420–41430. 2003. View Article : Google Scholar : PubMed/NCBI
23	Basson MA, Akbulut S, Watson-Johnson J, Simon R, Carroll TJ, Shakya R, Gross I, Martin GR, Lufkin T, McMahon AP, et al: Sprouty1 is a critical regulator of GDNF/RET-mediated kidney induction. Dev Cell. 8:229–239. 2005. View Article : Google Scholar : PubMed/NCBI
24	Klein OD, Minowada G, Peterkova R, Kangas A, Yu BD, Lesot H, Peterka M, Jernvall J and Martin GR: Sprouty genes control diastema tooth development via bidirectional antagonism of epithelial-mesenchymal FGF signaling. Dev Cell. 11:181–190. 2006. View Article : Google Scholar : PubMed/NCBI
25	Minowada G, Jarvis LA, Chi CL, Neubüser A, Sun X, Hacohen N, Krasnow MA and Martin GR: Vertebrate sprouty genes are induced by FGF signaling and can cause chondrodysplasia when overexpressed. Development. 126:4465–4475. 1999.PubMed/NCBI
26	Gross I, Armant O, Benosman S, de Aguilar JL, Freud JN, Kedinger M, Licht JD, Gaiddon C and Loeffler JP: Sprouty2 inhibits BDNF-induced signaling and modulates neuronal differentiation and survival. Cell Death Differ. 14:1802–1812. 2007. View Article : Google Scholar : PubMed/NCBI
27	Yue J and Tigyi G: Conservation of miR-15a/16-1 and miR-15b/16-2 clusters. Mamm Genome. 21:88–94. 2010. View Article : Google Scholar : PubMed/NCBI
28	Gao Y, Su J, Guo W, Polich ED, Magyar DP, Xing Y, Li H, Smrt RD, Chang Q and Zhao X: Inhibition of miR-15a promotes BDNF expression and rescues dendritic maturation deficits in MeCP2-deficient neurons. Stem Cells. 33:1618–1629. 2015. View Article : Google Scholar : PubMed/NCBI
29	Hebert SS, Horré K, Nicolaï L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN, Kauppinen S, Delacourte A and De Strooper B: Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci USA. 105:6415–6420. 2008. View Article : Google Scholar : PubMed/NCBI